Rapamycin inhibits vascular smooth muscle cell migration

The Journal of Clinical Investigation
M PoonA R Marks

Abstract

Abnormal vascular smooth muscle cell (SMC) proliferation and migration contribute to the development of restenosis after percutaneous transluminal coronary angioplasty and accelerated arteriopathy after cardiac transplantation. Previously, we reported that the macrolide antibiotic rapamycin, but not the related compound FK506, inhibits both human and rat aortic SMC proliferation in vitro by inhibiting cell cycle-dependent kinases and delaying phosphorylation of retinoblastoma protein (Marx, S.O., T. Jayaraman, L.O. Go, and A.R. Marks. 1995. Circ. Res. 362:801). In the present study the effects of rapamycin on SMC migration were assayed in vitro using a modified Boyden chamber and in vivo using a porcine aortic SMC explant model. Pretreatment with rapamycin (2 ng/ml) for 48 h inhibited PDGF-induced migration (PDGF BB homodimer; 20 ng/ml) in cultured rat and human SMC (n = 10; P < 0.0001), whereas FK506 had no significant effect on migration. Rapamycin administered orally (1 mg/kg per d for 7 d) significantly inhibited porcine aortic SMC migration compared with control (n = 15; P < 0.0001). Thus, in addition to being a potent immunosuppressant and antiproliferative, rapamycin also inhibits SMC migration.

References

May 1, 1991·Journal of the American College of Cardiology·J H IpJ H Chesebro
Jan 1, 1985·Circulation Research·A W Clowes, S M Schwartz
Jun 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·G R GrotendorstG R Martin
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·A M CameronS H Snyder
Jan 5, 1993·Journal of Molecular Biology·G D Van DuyneJ Clardy
Jan 28, 1994·Biochemical and Biophysical Research Communications·A P TimermanS Fleischer

❮ Previous
Next ❯

Citations

Mar 1, 2002·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Martin OberhoffKarl R Karsch
Mar 1, 2002·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Bonnie L HiattAndrew J Carter
Jul 19, 2002·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·David E KandzariJames P Zidar
Aug 31, 2002·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Kengo TanabePatrick W Serruys
Sep 1, 2004·Transplant International : Official Journal of the European Society for Organ Transplantation·Ondrej ViklickýUwe W Heemann
Jul 4, 2007·Journal of Materials Science. Materials in Medicine·C J PanN Huang
Jun 10, 2003·Current Atherosclerosis Reports·Juan F GranadaAlbert Raizner
May 20, 2004·Experimental Cell Research·Leise A BervenMichael F Crouch
Apr 20, 2004·Experimental Cell Research·P S WalmodE Bock
May 28, 2003·The American Journal of Cardiology·J Airton ArrudaValter C Lima
May 29, 2002·Cardiovascular Research·Pieter A Doevendans, Guillaume van Eys
Apr 18, 2002·Transplantation Proceedings·M RoquéE Roig
May 14, 2003·Transplantation Proceedings·J E SousaF Feres
May 14, 2003·Transplantation Proceedings·B Radovancevic, B Vrtovec
May 14, 2003·Transplantation Proceedings·J D MorrisettB D Kahan
May 14, 2003·Transplantation Proceedings·J F Trotter
May 14, 2003·Transplantation Proceedings·A R Marks
May 7, 2003·Trends in Cardiovascular Medicine·Ciro IndolfiDaniele Torella
Oct 31, 2003·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Peter N RuygrokAnne Keogh
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·R H RubinR E Morris
Feb 27, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Liqun MaZhiming Zhu
Nov 2, 2002·Nature Medicine·Victor J DzauDaniel G Sedding
Apr 23, 2002·Journal of Gastroenterology and Hepatology·Sarah Goddard, David H Adams
Oct 3, 2003·The New England Journal of Medicine·Andrew R Marks
Nov 21, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jian ShanAndrew R Marks
May 23, 2007·The Journal of Biological Chemistry·Noriko OshiroKazuyoshi Yonezawa
Nov 29, 2008·Cardiovascular Research·Fulvio MorelloEmilio Hirsch
Mar 12, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Josep M CruzadoJosep M Grinyó
Mar 9, 2000·Transplantation·O ViklickýU Heemann
Dec 19, 2006·Cardiology in Review·Leo SlavinJonathan M Tobis
Jan 31, 2009·Journal of Medical Imaging and Radiation Oncology·L G SahlerD L Waldman
Sep 2, 2008·Clinical and Experimental Pharmacology & Physiology·Jian ZhongZhiming Zhu
Dec 23, 2004·Kidney International. Supplement·José M Morales
Dec 13, 2002·Journal of Interventional Cardiology·P J De FeyterPatrick W Serruys
Aug 5, 2003·BMJ : British Medical Journal·Balram BhargavaRoxana Mehran
Jan 30, 2004·Annual Review of Medicine·T Cooper Woods, Andrew R Marks
Mar 27, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Pasithorn A SuwanabolK Craig Kent

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.